What's to stop the FDA enforcing 'patents' and market exclusivity in their approval process? I.e. Instead of approving Chemical-X, approve only DrugCorp brand Chemical-X?

Possibly with some stipulation that the first company to submit and pass approval gets a N-year exclusivity.